What a treatment is, who regulates it, and what to ask. 186 articles, newest first.
Botox temporarily blocks acetylcholine signaling to sweat glands through multiple injections; miraDry uses microwave energy to thermally damage underarm sweat glands. Both can address primary axillary hyperhidrosis, but duration, invasiveness, retreatment, compensatory expectations, and risk profiles differ.
Cellulite is not one removable substance. Visible dimples can involve fibrous septa, fat lobules, skin thickness and laxity, and anatomy. Tissue release, acoustic energy, radiofrequency, laser, massage, and fat treatments target different parts of that picture.
“Bioidentical” describes a hormone's chemical relationship to a hormone the body produces; it does not mean compounded, natural, safer, or FDA approved. FDA-approved bioidentical products exist, while compounded preparations are not FDA approved.
Compounded semaglutide and tirzepatide did not become generic Ozempic, Wegovy, Mounjaro, or Zepbound. In 2026, FDA policy sharpened the difference between individualized compounding and mass-marketed copies.
CoolSculpting is a cryolipolysis brand, Emsculpt is a product-family name used for electromagnetic muscle-stimulation services with model-specific claims, and liposuction surgically removes fat. None is weight-loss treatment or removes substantial loose skin.
Whole-body cryotherapy uses extremely cold air or vapor; a cold plunge uses water immersion. Their exposures, evidence, and operational risks are not interchangeable.
DEXA estimates bone mineral and soft tissue using low-dose X-rays; InBody-style bioimpedance estimates composition from electrical impedance; a 3D optical scan measures surface shape and predicts circumferences or composition. Their numbers should not be mixed into one trend line.
Electrolysis treats follicles one at a time with an inserted probe and electrical current; laser hair removal targets pigment across a larger area. Hair color, skin response, treatment area, time, maintenance, and the wording of the promised endpoint decide which comparison is useful.
A topical facial, product applied after microneedling, and an injection are different exposures. “Exosome” does not identify the source, contents, sterility, regulatory category, or evidence for any one of them.
Facial balancing is a marketing phrase for coordinating changes across facial features. It is not one procedure, diagnosis, formula, or FDA indication. A credible plan translates “balance” into named observations, measurable endpoints, exact products or procedures, staging, and stopping rules.
Kybella is the only FDA-approved fat-dissolving injectable, and its approval is for fat below the chin in adults. Injections marketed for the abdomen, arms, thighs, back, or other body areas are not FDA-approved uses, and many named products are unapproved.
IV, injected, and oral glutathione create different exposure, evidence, sourcing, and safety questions—especially for compounded sterile products and skin-lightening claims.
PRP, exosomes, minoxidil, finasteride, and low-level light therapy differ in evidence, approval, route, maintenance, and the hair-loss types they are meant to address. Diagnosis comes first.
Compare hormone pellets, patches, gels, and injections by product approval, absorption, dose adjustment, monitoring, and how quickly treatment can be changed or stopped.
FDA has not approved needle-free devices for injecting dermal filler and warns against their use. A hyaluron pen uses pressure rather than a needle, but that does not make placement controlled, the filler approved, or the service nonmedical.
HydraFacial is a branded tip-and-fluid workflow combining surface exfoliation, suction-based extraction, and solution delivery; microdermabrasion abrades the outer skin with a crystal or diamond-tip system and suction. Both are surface-focused, not substitutes for diagnosis or deeper resurfacing.
Hyperbaric oxygen therapy is a defined pressure-and-oxygen protocol for recognized medical uses. Wellness claims still need protocol-specific evidence, device identity, and oversight.
In this comparison, BBL means broadband light—not Brazilian butt lift. BBL is a branded form of intense pulsed light technology. IPL emits filtered ranges of noncoherent light; a laser emits a more specific coherent wavelength or set of wavelengths.
Kybella chemically disrupts submental fat cells through injections, noninvasive cooling injures susceptible fat cells through the skin, and liposuction surgically removes fat through a cannula. Skin laxity, anatomy, predictability, recovery, and tolerance for surgery usually matter more than the marketing label.
Darker skin is not excluded from laser and light treatment, but epidermal melanin can compete with the intended target. Safe planning requires the right diagnosis, wavelength or filter, pulse and cooling strategy, conservative endpoint, operator experience, and a plan for post-inflammatory darkening or lightening.
Laser resurfacing, chemical peels, and microneedling create controlled skin injury in different ways: light energy, a chemical agent, or mechanical needles. The useful comparison is target, device or product identity, depth, recovery, skin-tone risk, and operator controls.
Laser tattoo removal breaks selected ink pigments into smaller particles, but no device erases every tattoo on a fixed schedule. Ink colors, layers, depth, skin response, tattoo type, wavelength, operator, and healing between sessions determine the plan.
Lip filler migration can resemble swelling, placement, overfilling, tissue change, or nodules. Learn what dissolving can—and cannot—do and which warning signs are urgent.
A lip flip uses small, usually off-label doses of botulinum toxin to reduce upper-lip muscle pull; lip filler places an approved device material to add or shape tissue. They solve different problems, have different risk profiles, and should not be compared as interchangeable versions of lip enhancement.
A liquid rhinoplasty uses injectable filler to add temporary volume and camouflage selected contours; surgical rhinoplasty changes nasal structure and may address breathing. Filler does not make a nose smaller, and nasal filler is not an FDA-approved injection site.
Masseter toxin reduces activity in a chewing muscle, but jaw-slimming, bruxism, pain, and TMD claims are separate endpoints with different assessments and evidence.
Menopausal hormone therapy is intended for specific menopause symptoms and prevention indications under product labeling; aesthetic treatments target selected skin or contour findings. They can be discussed in the same life stage, but one should not be marketed as a substitute for the other.
IV NAD+, injections, oral NAD+ products, and precursors such as NR or NMN are not interchangeable. Delivery changes exposure, evidence, oversight, time, and the questions worth asking.
The viral name collapses several products into one phrase. PDRN, broader polynucleotide preparations, topical cosmetics, post-procedure products, and injections need separate evidence and regulatory checks.
A peptide is a type of molecule, not one treatment. BPC-157, CJC-1295, ipamorelin, and GHK-Cu have different evidence, approval, compounding, and route-specific questions.
PRP and PRF are autologous blood-derived preparations, but the labels do not define one universal product. Centrifuge force and time, tube additives, platelet and leukocyte content, activation, final volume, and delivery method can all change what is being used.
Noninvasive radiofrequency and focused ultrasound can heat tissue through different energy paths, but neither is a generic substitute for surgical skin removal. Compare the exact device, depth, indication, anatomy, settings logic, expected magnitude, and response plan.
Clinic panels and at-home masks can use similar color names while delivering different wavelengths, irradiance, dose, distance, coverage, and schedules. Those numbers matter more than brightness.
The FDA's 2025 communication did not reduce RF microneedling to a yes-or-no label. It made the device, operator, treatment area, settings, and response plan essential parts of the consultation.
A “Sculptra butt lift” injects poly-L-lactic acid off-label to stimulate tissue response; a Brazilian butt lift is gluteal fat-grafting surgery involving liposuction, fat processing, and subcutaneous placement. Sculptra is not FDA approved for buttock augmentation, and it is not a nonsurgical version of fat grafting.
Semaglutide is a GLP-1 receptor agonist; tirzepatide activates GIP and GLP-1 receptors. Approved obesity products have different labels, dose schedules, evidence, contraindications, coverage, and 2026 presentations, so the comparison must use exact brands and populations—not ingredient nicknames.
Skinvive is a specific FDA-approved dermal filler for cheek smoothness. “Skin booster” is a broad marketing category that can describe very different products and routes.
Peel depth describes the level of controlled chemical injury, not merely the percentage printed on a bottle. Superficial, medium, and deep peels differ in target, solution and application, recovery, pigment risk, monitoring, and the clinical setting needed to manage injury.
Threads apply limited mechanical suspension, filler adds or redistributes volume, and facelift surgery repositions deeper tissue and removes selected excess skin. They address different problem definitions and have very different evidence, durability, recovery, and risk profiles.
Under-eye filler, platelet-rich fibrin, and lower blepharoplasty do not solve the same problem. Filler places volume, PRF uses an autologous blood-derived preparation with less certain aesthetic evidence, and surgery can reposition or remove fat and address skin or lid structure.
“Vaginal rejuvenation” can bundle cosmetic, menopausal, sexual-function, and urinary claims that require different evaluations. FDA has not approved laser or energy-based treatment for vaginal cosmetic surgery or these symptom claims, and current guidelines find the evidence insufficient for routine GSM treatment.
Hydration, vitamin, and NAD+ drips are common across South Florida. Here is how to identify the ingredients, the source, the responsible clinician, and the process around an infusion.
